Total planned funding: $480,994,710
Clear active filters
FHI 360
NGO
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $87,481,571 |
Nigeria | $77,823,933 |
South Africa | $50,911,972 |
Zimbabwe | $33,812,624 |
Asia Regional Program | $28,271,438 |
Zambia | $23,961,907 |
Tanzania | $21,727,369 |
West Africa Region | $18,148,918 |
Kenya | $17,335,415 |
Botswana | $13,614,006 |
Democratic Republic of the Congo | $13,313,530 |
Vietnam | $11,141,176 |
Burundi | $10,840,637 |
Côte d'Ivoire | $9,651,138 |
India | $8,414,357 |
Malawi | $8,067,705 |
Dominican Republic | $6,048,850 |
Papua New Guinea | $5,981,191 |
Indonesia | $5,231,794 |
Eswatini | $5,118,942 |
Uganda | $4,919,324 |
Angola | $4,716,719 |
Haiti | $2,616,452 |
Caribbean Region | $2,525,420 |
Ethiopia | $2,373,578 |
Cambodia | $2,025,000 |
Lesotho | $1,888,960 |
Rwanda | $1,713,822 |
South Sudan | $566,962 |
Namibia | $450,000 |
enumerations.Philippines | $300,000 |
Central Asia Region | $0 |
Ghana | $0 |
Organizational Types
NGO | $480,994,710 |
Program Areas
Treatment | $150,654,457 |
Care | $123,802,926 |
Prevention | $110,527,327 |
Testing | $55,537,981 |
Governance and Systems | $40,309,725 |
Management and Operations | $162,294 |
Budget Codes
HTXS: Treatment: Adult Treatment | $139,999,387 |
HVOP: Sexual Prevention: Other Sexual Prevention | $76,452,341 |
HKID: Care: Orphans and Vulnerable Children | $72,607,837 |
HVCT: Testing: HIV Testing and Counseling | $55,537,981 |
HBHC: Care: Adult Care and Support | $34,462,129 |
OHSS: Health Systems Strengthening | $17,288,430 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $16,095,936 |
HVSI: Strategic Information | $12,421,990 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,696,395 |
PDTX: Treatment: Pediatric Treatment | $10,655,070 |
HLAB: Laboratory Infrastructure | $10,599,305 |
PDCS: Care: Pediatric Care and Support | $9,270,235 |
HVTB: Care: TB/HIV | $7,462,725 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,483,819 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $3,039,031 |
HMBL: Biomedical Prevention: Blood Safety | $393,361 |
HMIN: Biomedical Prevention: Injection Safety | $366,444 |
HVMS: Management and Operations | $162,294 |
HTXD: Treatment: ARV Drugs | $0 |
Top Partner Programs
FHI 360:
$480,994,710
View countries